quinuclidines has been researched along with tiotropium bromide in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 24 (75.00) | 24.3611 |
| 2020's | 8 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amari, G; Bassani, F; Battipaglia, L; Bergamaschi, M; Berti, F; Bolzoni, PT; Cacciani, F; Cenacchi, V; Civelli, M; Delcanale, M; Geppetti, PA; Harrison, S; Mannini, F; Pastore, F; Patacchini, R; Petrillo, P; Razzetti, R; Rizzi, A; Rossoni, G; Santoro, E; Scudellaro, R; Villetti, G; Volta, R; Zaniboni, M | 1 |
| Bengtsson, T; Bjermer, L; Jorup, C; Lötvall, J | 1 |
| Barrett, VJ; Buckley, PT; Burman, M; DeHaas, CJ; Foley, JJ; Hay, DW; Kotzer, CJ; Lainé, DI; Luttmann, MA; Palovich, MR; Rumsey, WL; Salmon, M; Sarau, HM; Schmidt, DB; Slack, RJ; Webb, EF | 1 |
| Banerji, D; Bateman, ED; Mahler, DA; Patalano, F; Vogelmeier, CF; Wedzicha, JA | 1 |
| Anzueto, A; Church, A; Crater, G; Decramer, M; Harris, S; Kaelin, T; Kerwin, E; Richard, N; Tabberer, M | 1 |
| Sin, DD | 1 |
| Beerahee, M; Church, A; Donohue, JF; Gunawan, R; Kalberg, C; Mehta, R; Shah, P | 1 |
| Church, A; Kaelin, T; Maleki-Yazdi, MR; Richard, N; Zvarich, M | 1 |
| Neffen, H; Rodrigo, GJ | 1 |
| Nagy, LB | 1 |
| Huisman, EL; Ismaila, AS; Karabis, A; Punekar, YS | 1 |
| Carcedo, D; Gáldiz, JB; Garcia-Rio, F; Huerta, A; Miravitlles, M; Villacampa, A | 1 |
| Fahy, WA; Galkin, D; Kalberg, C; Newlands, A; O'Dell, D | 1 |
| Church, A; Fahy, WA; Feldman, G; Khindri, S; Maltais, F; Trivedi, R; Vahdati-Bolouri, M | 1 |
| Kuwahira, I | 1 |
| Anzueto, A; Fahy, WA; Maleki-Yazdi, MR; Naya, I; Singh, D; Tombs, L | 1 |
| Kardos, P; Müllerová, H; Newby, DE; Román-Rodríguez, M; Singh, D; Worsley, S | 1 |
| Thomson, NC | 1 |
| Coleman, A; Earnshaw, SR; McDade, CL; Patel, JG; Stanford, RH; Wilson, MR | 1 |
| Deas, SD; Huprikar, N | 1 |
| Crisafulli, E; Torres, A | 1 |
| Blauer-Peterson, C; Buikema, AR; Hahn, B; Hull, M; Ray, R; Stanford, RH | 1 |
| Alcázar-Navarrete, B; Asukai, Y; Driessen, MT; García-Río, F; Miravitlles, M; Naya, IP; Risebrough, NA; Seewoodharry Buguth, B; Vallejo-Aparicio, LA; Whalen, J | 1 |
| Lad, R; Rhee, CK; Yoshisue, H | 1 |
| Belardo, C; Cazzola, M; Matera, MG; Rinaldi, B; Rinaldi, M | 1 |
| Aguiar, R; Luz, MI; Morais-Almeida, M | 1 |
| Hanada, S; Kunita, Y; Muraki, M; Sawaguchi, H; Shirahase, K; Tohda, Y; Yamazaki, R | 1 |
| Duh, MS; Germain, G; Hahn, B; Laliberté, F; Mahendran, M; Moretz, C; Ray, R; Shen, Q; Slade, D | 1 |
| Chan, MC; Chen, NH; Cheng, SL; Hsieh, MJ; Hsu, WH; Kuo, PH; Lin, MS; Liu, CL; Liu, SF; Tao, CW; Tsai, YH; Wei, YF; Wu, YK; Yang, TM | 1 |
| Agarwal, J; Compton, C; Czira, A; Dong, X; Duarte, M; Haeussler, K; Halpin, DMG; Ismaila, AS; Malmenäs, M; Nassim, M; Shen, Y; Tongbram, V; Vogelmeier, CF; Živković-Gojović, M | 1 |
| Bengtson, LGS; Buysman, EK; Clark, B; Ferguson, GT; Palli, S; Sargent, A; Sethi, S; Shaikh, A | 1 |
| Banks, V; Castillo, CM; Compton, C; Czira, A; Herth, F; Ismaila, AS; Quint, JK; Requena, G; Rothnie, KJ; Tritton, T; Wild, R; Wood, R; Yeap, J | 1 |
12 review(s) available for quinuclidines and tiotropium bromide
| Article | Year |
|---|---|
Recent advances in COPD disease management with fixed-dose long-acting combination therapies.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Disease Management; Disease Progression; Drug Combinations; Ethanolamines; Formoterol Fumarate; Glycopyrrolate; Humans; Indans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome | 2014 |
A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Androstadienes; Benzyl Alcohols; Chlorobenzenes; Drug Combinations; Fluticasone-Salmeterol Drug Combination; Humans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome | 2015 |
[Are there cardiovascular adverse effects of inhaled anticholinergics?].
Topics: Administration, Inhalation; Bronchodilator Agents; Cardiovascular Diseases; Cardiovascular System; Cholinergic Antagonists; Clinical Trials as Topic; Glycopyrrolate; Humans; Incidence; Ipratropium; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Risk Factors; Scopolamine Derivatives; Tiotropium Bromide | 2015 |
Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.
Topics: Aged; Bayes Theorem; Bronchodilator Agents; Drug Administration Schedule; Female; Forced Expiratory Volume; Glycopyrrolate; Humans; Lung; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Randomized Controlled Trials as Topic; Recovery of Function; Spirometry; Surveys and Questionnaires; Time Factors; Tiotropium Bromide; Treatment Outcome; Tropanes | 2015 |
[LAMA/LABA fixed dose combination for treatment of COPD].
Topics: Adrenergic beta-2 Receptor Agonists; Benzoxazines; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Delayed-Action Preparations; Drug Combinations; Forced Expiratory Volume; Glycopyrrolate; Humans; Indans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines; Respiratory Function Tests; Tiotropium Bromide; Treatment Outcome | 2016 |
New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Drug Discovery; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukotriene Antagonists; Long-Term Care; Macrolides; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Protein Kinase Inhibitors; Quinuclidines; Small Molecule Libraries; Tiotropium Bromide | 2017 |
Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and Safety of fixed dose combination treatments in the setting of recent guideline updates.
Topics: Administration, Inhalation; Benzoxazines; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Delayed-Action Preparations; Drug Combinations; Formoterol Fumarate; Glycopyrrolate; Humans; Indans; Muscarinic Antagonists; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines; Tiotropium Bromide; Tropanes | 2018 |
COPD 2017: A Year in Review.
Topics: Androstadienes; Antibodies, Monoclonal, Humanized; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Common Cold; Disease Progression; Drug Combinations; Eosinophils; Glucocorticoids; Haemophilus Infections; Humans; Interleukin-5; Moraxellaceae Infections; Muscarinic Antagonists; Noninvasive Ventilation; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Seasons; Severity of Illness Index; Tiotropium Bromide | 2018 |
Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Asian People; Benzoxazines; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Formoterol Fumarate; Glycopyrrolate; Humans; Indans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines; Tiotropium Bromide; Treatment Outcome; Tropanes | 2019 |
New perspectives on the role of muscarinic antagonists in asthma therapy.
Topics: Adrenal Cortex Hormones; Asthma; Drug Therapy, Combination; Glycopyrrolate; Humans; Muscarinic Antagonists; Quinuclidines; Tiotropium Bromide | 2020 |
The reality of LAMAs for adult asthmatic patients.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Age of Onset; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Muscarinic Antagonists; Quinuclidines; Tiotropium Bromide | 2020 |
Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Dyspnea; Forced Expiratory Volume; Glycopyrrolate; Humans; Muscarinic Antagonists; Network Meta-Analysis; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Salmeterol Xinafoate; Tiotropium Bromide; Treatment Outcome | 2022 |
9 trial(s) available for quinuclidines and tiotropium bromide
| Article | Year |
|---|---|
Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD.
Topics: Administration, Inhalation; Aged; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Piperidines; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Receptor, Muscarinic M3; Scopolamine Derivatives; Tiotropium Bromide | 2013 |
Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.
Topics: Administration, Inhalation; Aged; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Scopolamine Derivatives; Time Factors; Tiotropium Bromide; Treatment Outcome | 2014 |
Dose response of umeclidinium administered once or twice daily in patients with COPD: a pooled analysis of two randomized, double-blind, placebo-controlled studies.
Topics: Aged; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Scopolamine Derivatives; Tiotropium Bromide | 2014 |
Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial.
Topics: Aged; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinuclidines; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome | 2014 |
Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Humans; Indans; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines; Tiotropium Bromide; Treatment Outcome | 2016 |
A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.
Topics: Cholinergic Antagonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Tiotropium Bromide; Treatment Outcome | 2016 |
Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Tiotropium Bromide; Treatment Outcome | 2017 |
Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Topics: Aged; Benzoxazines; Benzyl Alcohols; Chlorobenzenes; Cost-Benefit Analysis; Cross-Over Studies; Drug Combinations; Female; Humans; Male; Middle Aged; National Health Programs; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Single-Blind Method; Spain; Tiotropium Bromide | 2018 |
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Benzoxazines; Cross-Over Studies; Disease Progression; Drug Administration Schedule; Drug Combinations; Female; Forced Expiratory Volume; Humans; Japan; Male; Middle Aged; Muscarinic Antagonists; Nebulizers and Vaporizers; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Tiotropium Bromide; Treatment Outcome | 2021 |
11 other study(ies) available for quinuclidines and tiotropium bromide
| Article | Year |
|---|---|
Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Topics: Acetylcholine; Aged; Anesthesia; Animals; Blood Pressure; Bronchi; Bronchial Spasm; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Carbachol; Carbamates; CHO Cells; Cricetinae; Cricetulus; Diamines; Guinea Pigs; Heart Atria; Heart Rate; Humans; Kinetics; Male; Middle Aged; Molecular Structure; Muscarinic Antagonists; Myocardial Contraction; Quinuclidines; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Scopolamine Derivatives; Tiotropium Bromide; Trachea; Transfection; Ventricular Function, Left | 2010 |
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Topics: Administration, Inhalation; Animals; Calcium; Carbachol; CHO Cells; Cholinergic Antagonists; Cricetinae; Cricetulus; Guinea Pigs; Kinetics; Lung; Lung Diseases; Mice; Mice, Inbred BALB C; Muscarinic Agonists; Muscarinic Antagonists; Plethysmography; Quinuclidines; Receptor, Muscarinic M3; Receptors, Muscarinic; Scopolamine Derivatives; Tiotropium Bromide | 2013 |
Wanted: new treatments for COPD.
Topics: Benzyl Alcohols; Chlorobenzenes; Female; Humans; Male; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Scopolamine Derivatives; Tiotropium Bromide | 2014 |
Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients.
Topics: Administration, Inhalation; Aged; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Cost-Benefit Analysis; Drug Combinations; Female; Forced Expiratory Volume; Humans; Longitudinal Studies; Male; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinuclidines; Severity of Illness Index; Spain; Symptom Assessment; Tiotropium Bromide; Treatment Outcome | 2016 |
Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Benzyl Alcohols; Bronchodilator Agents; Cardiovascular Diseases; Chlorobenzenes; Comorbidity; Drug Combinations; Evidence-Based Medicine; Humans; Lung; Muscarinic Antagonists; Patient Safety; Patient Selection; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Risk Factors; Time Factors; Tiotropium Bromide; Treatment Outcome | 2016 |
Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Humans; Markov Chains; Models, Economic; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinuclidines; Severity of Illness Index; Time Factors; Tiotropium Bromide; Treatment Outcome | 2017 |
Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA.
Topics: Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Benzyl Alcohols; Chlorobenzenes; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Retrospective Studies; Tiotropium Bromide; Treatment Outcome | 2018 |
Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Databases, Factual; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Propensity Score; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Retrospective Studies; Time-to-Treatment; Tiotropium Bromide; United States | 2021 |
Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study.
Topics: Adrenergic beta-2 Receptor Agonists; Benzoxazines; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Glycopyrrolate; Humans; Indans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines; Retrospective Studies; Taiwan; Tiotropium Bromide; Treatment Outcome | 2022 |
Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History.
Topics: Administration, Inhalation; Adult; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Fluticasone; Humans; Patient Acceptance of Health Care; Pneumonia; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Tiotropium Bromide | 2023 |
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England.
Topics: Administration, Inhalation; Adult; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Drug Prescriptions; Forced Expiratory Volume; Humans; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Retrospective Studies; Tiotropium Bromide; Treatment Outcome | 2023 |